BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
GATA1
,
Fatty acid metabolic process
,
Obesity
,
Prostate
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PSC 833
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients W…
Valspodar limits human cytomegalovirus infection and dissemination.
Optimization of dose and route of administration of the P-glycoprotein inhibitor, valspodar (PSC-833…
Improving Treatment Efficacy of In Situ Forming Implants via Concurrent Delivery of Chemotherapeutic…
Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rap…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other A…
A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metas…
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemi…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ